Sulfates are main targets of immune responses to cruzipain and are involved in heart damage in BALB/c immunized mice

International Immunology

Volumn 20, Issue 4, 2008, Pages 461-470

  Acosta, Diana Maria ^a   Arnaiz, Maria Rosa ^a   Esteva, Mónica Inés ^a   Barboza, Mariana ^a   Stivale, Diana ^b   Orlando, Ulises Daniel ^a   Torres, Susana ^c   Laucella, Susana Adriana ^a,c   Couto, Alicia Susana ^b   Duschak, Vilma Gladys ^a  

^a Administracion Nacional de Laboratorios E Institutos de Salud Dr Carlos G Malbran   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c Hospital Interzonal General de Agudos Eva Peronquot   (Argentina)

Author keywords

C T domain; Cruzipain; Glycoprotein; Sulfated epitopes; Trypanosoma cruzi

Indexed keywords

ANTIGEN; CRUZIPAIN; EPITOPE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G2B; SULFATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; CARBOXY TERMINAL SEQUENCE; CELLULAR IMMUNITY; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DISEASE COURSE; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; HEART INJURY; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PARASITOSIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN TARGETING; SEROLOGY; TRYPANOSOMA CRUZI;

ANIMALS; CHAGAS DISEASE; CHRONIC DISEASE; CYSTEINE ENDOPEPTIDASES; DISEASE MODELS, ANIMAL; FEMALE; HEART DISEASES; HUMANS; HYPERSENSITIVITY, DELAYED; IMMUNOGLOBULIN G; INJECTIONS, SUBCUTANEOUS; MICE; MICE, INBRED BALB C; MYOCARDIUM; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, TERTIARY; REPRODUCIBILITY OF RESULTS; SEROLOGIC TESTS; SULFATES; TRYPANOSOMA CRUZI;

EID: 41149162762     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxm149     Document Type: Article

References (62)

1. World Bank/World Health Organization 2002. UNDP/World Bank/WHO special programme for research and training in tropical diseases control of Chagas disease. Report of a WHO Expert Committee World Health Program. Tech. Rep. Ser. 905:1.
2. Pan American Health Organization 1984. Status of Chagas disease in the region of Americas. Epidemiol. Bull. 5.
3. Cazzulo, J. J., Stoka, V. and Turk, V. 2001. The major cysteine proteinase of Trypanosoma cruzi: A valid target for chemotherapy of Chagas disease. Curr. Pharm. Des. 7:1143.
4. Coombs, G. H. and Mottram, J. C. 1997. Proteinases of trypanosomes and Leishmania. In Hide, G., Mottram, J. C., Coombs, G. H. and Holmes, P. H., eds, Trypanosomiasis and Leishmaniasis, p. 177., CAB International, Oxford.
5. Sharfstein, J., Schechter, M., Senna, M., Peralta, J. M., Mendonca-Previato, L. and Miles, M. M. 1986. Trypanosoma cruzi: characterization and isolation of a 57/51,000 m.w. surface glycoprotein (GP57/51) expressed by epimastigotes and blood-stream trypomastigotes. J. Immunol. 137:1336.
6. Martinez, J., Campetella, O., Frasch, A. C.C. and Cazzulo, J. J. 1991. The major cysteine proteinase (cruzipain) from Trypanosoma cruzi is antigenic in human infections. Infect. Immun. 59:4275.
7. Martinez, J., Campetella, O., Frasch, A. C.C. and Cazzulo, J. J. 1993. The reactivity of sera from chagasic patients against different fragments of cruzipain, the major cysteine proteinase from Trypanosoma cruzi, suggests the presence of defined antigenic and catalytic domains. Immunol. Lett. 35:191.
8. Souto-Padron, T., Campetella, O., Cazzulo, J. J. and De Souza, W. 1990. Cysteine proteinases in T. cruzi immunocytochemical localization and involvement in parasite-host cell interaction. J. Cell Sci. 96:485.
9. Parussini, F., Duschak, V. G. and Cazzulo, J. J. 1998. Membrane bound cysteine proteinase isoforms in different developmental stages of Trypanosoma cruzi. Cell. Mol. Biol. 44:513.
10. Duschak, V. G., Barboza, M. and Couto, A. S. 2003. Trypanosoma cruzi partial characterization of minor cruzipain isoforms non-adsorbed to Concanavalin A-Sepharose. Exp. Parasitol. 104:122.
11. Yokoyama-Yasunaka, J. K.U., Pral, E. M.F., Oliveira, O. C., Alfieri, S. C. and Stolf, A. M.S. 1994. Trypanosoma cruzi: Identification of proteinases in shed components of trypomastigote forms. Acta Trop. 57:307.
12. Duschak, V. G., Barboza, M., Garcia, G. A., Lammel, E. M., Couto, A. S. and Isola, E. L. 2006. Novel cysteine proteinase in Trypanosoma cruzi metacyclogenesis. Parasitology. 132:345.
13. Giordanengo, L., Maldonado, C., Rivarola, H. W. et al. 2000. Induction of antibodies reactive to cardiac myosin and development of heart alterations in cruzipain-immunized mice and their offspring. Eur. J. Immunol. 30:3181.
14. Schnapp, A. R., Eickhoff, C. S., Sizemore, D., Curtiss, R. and Hoft, D. F. 2002. Cruzipain induces both mucosal and systemic protection against Trypanosoma cruzi in mice. Infect. Immun. 70:5065.
15. Arnholdt, A. C.V., Piuvezam, M. R., Russo, D. M. et al. 1993. Analysis and partial epitope mapping of human T cell responses to Trypanosoma cruzi cysteinyl proteinase. J. Immunol. 151:3171.
16. Murta, A. C., Leme, V. C., Milani, S. R., Travassos, L. R. and Scharfatein, J. 1988. Glycoprotein GP57/51 of Trypanosoma cruzi: structural and conformational epitopes defined with monoclonal antibodies. Mem. Inst. Oswaldo Cruz 83(Suppl. 1):419.
17. Morrot, A., Strickland, D. K., Higuchi, M.de M. L., Reis, M., Pedrosa, R. and Scharfstein, J. 1997. Human T cell responses against the major cysteine proteinase (cruzipain) of Trypanosoma cruzi: Role of the multifunctional alpha 2-macroglobulin receptor in antigen presentation by monocytes. Int. Immunol. 9:825.
18. Giordanengo, L., Guiñazú, N., Stempin, C., Fretes, R., Cerbán, F. and Gea, S. 2002. Cruzipain, a major Trypanosoma cruzi antigen, conditions the host immune response in favour of the parasite. Eur. J. Immunol. 32:1003.
19. Duschak, V. G., Riarte, A., Segura, E. L. and Laucella, S. A. 2001. Humoral immune response to cruzipain and cardiac dysfunction in chronic Chagas disease. Immunol. Lett. 78:135.
20. Petry, K., Nudelman, E., Eisen, H. and Hakomori, S. 1988. Sulfated lipids represent common antigens on the surface of Trypanosoma cruzi and mammalian tissues. Mol. Biochem. Parasitol. 30:113.
21. Uhrig, M. L., Couto, A. S., Zingales, B., Colli, W. and Lederkremer, R. M. 1992. Metabolic labelling and partial characterization of a sulfoglycolipid in Trypanosoma cruzi trypomastigotes. Carbohydr. Res. 231:329.
22. Barboza, M., Duschak, V. G., Fukuyama, Y. et al. 2005. Structural analysis of the N-glycans present in cruzipain, the major cysteine proteinase of Trypanosoma cruzi. Identification of sulfated high-mannose type oligosaccharides. FEBS J. 272:3803.
23. Wynne de Martini, G. J., Abramo Orrego, L., de Rissio, A. M., Alvarez, M. and Mujica, L. P. 1980. Cultivo de Trypanosoma cruzi en un medio monofásico. Medicina (B Aires). 40:109.
24. Labriola, C., Souza, M. and Cazzulo, J. J. 1993. Purification of the major cysteine proteinase (cruzipain) from Trypanosoma cruzi by affinity chromatography. Biol. Res. 26:101.
25. Parussini, F., Garcia, M., Mucci, J. et al. 2003. Characterization of a lysosomal serinecarboxypeptidase from Trypanosoma cruzi. Mol. Biochem. Parasitol. 131:11.
26. Barboza, M., Duschak, V. G., Cazzulo, J. J., Lederkremer, R. M. and Couto, A. S. 2003. Presence of sialic acid in N-linked oligosaccharide chains and O-linked N-acetylglucosamine in cruzipain, the major cysteine proteinase of Trypanosoma cruzi. Mol. Biochem. Parasitol. 27:69.
27. Freeze, H. H., Yeh, R., Miller, A. L. and Kornfeld, S. 1983. Structural analysis of the asparagine-linked oligosaccharides from free lysosomal enzymes of Dictyostelium discoideum. J. Biol. Chem. 258:14874.
28. World Health Organization Control of Chagas disease. Report of a WHO Expert Committee World Health Program. Tech. Rep. Ser. 811:1.
29. Kuschnir, E., Sgammini, H., Castro, R., Evequoz, C., Ledesma, R. and Brunetto, J. 1985. Evaluation of cardiac function by radioisotopic angiography, in patients with chronic Chagas cardiopathy. Arq. Bras. Cardiol. 45:249.
30. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:680.
31. Oakley, B. R., Kirsch, D. R. and Morris, R. 1980. A simplified ultrasensitive silver stain for detecting proteins in polyacrylamide gels. Anal. Biochem. 105:361.
32. Duschak, V. G., Ciaccio, M., Nasser, J. R. and Basombrío, M. A. 2001. Enzymatic activity, protein expression and gene sequence of cruzipain in virulent and attenuated Trypanosoma cruzi strains. J. Parasitol. 87:1016.
33. Bradford, J. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248.
34. Del Nery, E., Juliano, M. A., Lima, A. P.C. A., Scharfstein, J. and Juliano, L. 1997. Kininogenase activity by the major cysteinyl proteinase (cruzipain) from Trypanosoma cruzi. J. Biol. Chem. 272:25713.
35. Scharfstein, J. and Morrot, A. 1999. A role for extracellular amastigotes in the immunopathology of Chagas disease. Mem. Inst. Oswaldo Cruz. 94:51.
36. Laderach, D., Cerbán, F., Motran, C., Vottero de Cima, E. and Gea, S. 1996. Trypanosoma cruzi: The major cysteinyl proteinase (cruzipain) is a relevant immunogen of parasite acidic antigens (FIII). Int. J. Parasitol. 26:1249.
37. Pedrosa, R. C., Saad, E. A., Scharfstein, J. and Lima, A. M. 1996. The proliferative response of T cells against cruzipain in chronic chagasic cardiopathy. Rev. Soc. Bras. Med. Trop. 29:331.
38. Klemba, M. and Goldberg, D. E. 2002. Biological roles of proteases in parasitic protozoa. Annu. Rev. Biochem. 71:275.
39. McKerrow, J. H., Mc Grath, M. E. and Engel, J. C. 1995. The cysteine protease of Trypanosoma cruzi as a model for antiparasite drug design. Parasitol. Today. 11:279.
40. Duschak, V. G. and Couto, A. S. 2007. An insight on targets and patented drugs for chemotherapy of Chagas disease. A Review. Recent Patents Ant-Infect. Drug Discov. 2:19.
41. Bernstein, H. B. and Compans, R. W. 1992. Sulfation of the human immunodeficiency virus envelope glycoprotein. J. Virol. 66:6953.
42. Kawasaki, N., Haishima, Y., Ohta, M. et al. 2001. Structural analysis of sulfated N-linked oligosaccharides in erythropoietin. Glycobiology 11:1043.
43. Van Rooijen, J. J., Kamerling, J. P. and Vliegenthart, J. F. 1998. Sulfated di-, tri-and tetra-antennary N-glycans in human Tamm-Horsfall glycoprotein. Eur. J. Biochem. 256:471.
44. Noguchi, N. and Nakano, M. 1992. Structure of the acidic N-linked carbohydrate chains of the 55-kDa glycoprotein family (PZP3) from porcine zona pellucida. Eur. J. Biochem. 213:39.
45. Kawasaki, N., Ohta, M., Hyuga, S., Hashimoto, O. and Hayakawa, T. 2000. Application of liquid chromatography/mass spectrometry and liquid chromatography with tandem mass spectrometry to the analysis of the site-specific carbohydrate heterogeneity in erythropoietin. Anal. Biochem. 285:82.
46. Honke, K. and Taniguchi, N. 2002. Sulfotransferases and sulfated oligosaccharides. Med. Res. Rev. 22:637.
47. Freeze, H. H. and Wolgast, D. 1986. Structural analysis of the N-linked oligosaccharides glycoproteins secreted by Dictyostelium discoideum Identification of mannose-6-sulfate. J. Biol. Chem. 261:127.
48. Brodskyn, C., Silva, A., Takehara, H. and Mota, I. 1989. IgG subclasses responsible for immune clearance in mice infected with Trypanosoma cruzi. Immunol. Cell Biol. 67:343.
49. Rowland, E. C., Mikhail, K. S. and McCormick, T. S. 1992. Isotype determination of anti-Trypanosoma cruzi antibody in murine Chagas' disease. J. Parasitol. 78:557.
50. Cordeiro Drumond, F., Assis, O., Da Costa, M. O., Jorge, S., Correa-Oliveira, R. and Romanha, A. J. 2001. Anti-Trypanosoma cruzi immunoglobulin G1 can be useful tool for diagnosis and Prognosis of human Chagas' disease. Clin. Diagn. Lab. Immunol. 8:112.
51. Fiorentino, B. F., Bond, M. W. and Mosmann, T. R. 1989. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170:2081.
52. Hoft, D. F., Lynch, R. G. and Kirchhoff, L. V. 1993. Kinetic analysis of antigen-specific immune responses in resistant and susceptible mice during infection with Trypanosoma cruzi. J. Immunol. 151:7038.
53. Jankovic, D., Zhugong, L. and Gause, W C. 2001. Th1 and Th2-cell commitment during infectious disease: Asymmetry in divergent pathways. Trends Immunol. 22:450.
54. Laucella, S. A., Postam, M., Martin, D. et al. 2004. Frequency of interferon- gamma-producing T cells specific for Trypanosoma cruzi inversely correlates with disease severity in chronic human Chagas disease. J. Infect. Dis. 189:909.
55. Albareda, M. C., Laucella, S. A., Alvarez, M. G. et al. 2006. Trypanosoma cruzi modulates the profile of memory CD8+ T cells in chronic Chagas' disease patients. Int. Immunol. 18:465.
56. Schmitz, J., Kuroda, M. J., Santra, S. et al. 2003. Effect of humoral immune responses on controlling viremia during primary infection of rhesus monkeys with simian immunodeficiency virus. J. Virol. 77:2165.
57. Aucan, C., Traore, Y., Tall, F. et al. 2000. High immunoglobulin G2 (IgG2) and low IgG4 levels are associated with human resistance to Plasmodium falciparum malaria. Infect. Immun. 68:1252.
58. Muller, I., Kropf, P., Etges, R. J. and Louis, J. A. 1993. Gamma interferon response in secondary Leishmania major infection: Role of CD8+ T cells. Infect. Immun. 61:3730.
59. Bunce, C. and Bell, E. B. 1997. CD45RC isoforms define two types of CD4 memory T cells, one of which depends on persisting antigen. J. Exp. Med. 185:767.
60. Black, C. A. 1999. Delayed type hypersensitivity, current theories with an historic perspective. Dermatol. Online J. 5:7.
61. Liu, Y., Misulovin, Z. and Bjorkman, P. J. 2001. The molecular mechanism of sulfated carbohydrate recognition by the cysteine-rich domain of mannose receptor. J. Mol. Biol. 305:481.
62. Linehan, S. A. 2005. The mannose receptor is expressed by subsets of APC in non-lymphoid organs. BMC Immunol. 6:4.